PHK
AVNS

Point72 Hong Kong’s Avanos Medical AVNS Stock Holding History

Point72 Hong Kong’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-756
Closed -$21K – 1922
2022
Q2 		$21K Buy
+756
New +$21.7K ﹤0.01% 1547
2021
Q4 		– Sell
-6,509
Closed -$203K – 1882
2021
Q3 		$203K Buy
6,509
+6,091
+1,457% +$207K 0.01% 1164
2021
Q2 		$15K Buy
+418
New +$17.3K ﹤0.01% 1675
2021
Q1 		– Sell
-1,820
Closed -$84K – 1795
2020
Q4 		$84K Buy
+1,820
New +$75.8K ﹤0.01% 1100
2018
Q4 		– Sell
-176
Closed -$12K – 885
2018
Q3 		$12K Sell
176
-3,159
-95% -$203K ﹤0.01% 649
2018
Q2 		$191K Buy
+3,335
New +$176K 0.06% 183
2017
Q3 		– Sell
-3,186
Closed -$125K – 794
2017
Q2 		$125K Buy
+3,186
New +$120K 0.13% 78
2017
Q1 		– Sell
-76
Closed -$3K – 737
2016
Q4 		$3K Buy
+76
New +$2.72K ﹤0.01% 747
2015
Q1 		– Sell
-434
Closed -$20K – 268
2014
Q4 		$20K Buy
+434
New +$17.1K 0.02% 442

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Point72 Hong Kong's AVNS Position: Q3 2022 in Review

Point72 Hong Kong sold out of Avanos Medical (AVNS) in Q3 2022, closing a stake of 756 shares — an estimated $21K sold.

Point72 Hong Kong first reported a position in AVNS in Q4 2014 and held it in 9 quarters. The position peaked at $203K in Q3 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

  • Point72 Hong Kong reported no remaining Avanos Medical position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 756 Avanos Medical shares in Q3 2022, an estimated $21K.
  • Point72 Hong Kong first reported a position in Avanos Medical in Q4 2014 and held it in 9 quarters.
  • Point72 Hong Kong's Avanos Medical position peaked at $203K in Q3 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.